--- title: "Adaptive Radiotherapy for Liver Cancer | 5D Cancer Services — St. George, UT" description: "Evidence-based guide to adaptive SBRT for liver cancer and liver metastases. The Gemini 360 tracks respiratory liver motion for precise treatment in 3–5 sessions. Serving St. George, UT, Nevada, and Arizona." canonical: https://www.5dcancerservices.com/adaptive-radiotherapy/liver route: /adaptive-radiotherapy/liver type: article lastUpdated: 2026-06-15 keywords: ["adaptive radiotherapy", "Akesis Gemini 360", "5D Cancer Services", "St. George Utah", "radiation oncology", "liver cancer", "liver SBRT", "HCC radiation", "hepatocellular carcinoma treatment", "liver metastases radiation", "liver stereotactic body radiation"] --- # Adaptive Radiotherapy for Liver Cancer | 5D Cancer Services — St. George, UT > Evidence-based guide to adaptive SBRT for liver cancer and liver metastases. The Gemini 360 tracks respiratory liver motion for precise treatment in 3–5 sessions. Serving St. George, UT, Nevada, and Arizona. - HomeTechnologyAdaptive RTClinical DataConditionsInsuranceOur TeamFAQ (435) 900-7060Please do not send Protected Health Information (PHI) by email or voicemail. Standard email is not secure — call us and we will arrange a secure channel.Home - Adaptive Radiotherapy - Liver CancerQuick summaryAdaptive SBRT for liver cancer at 5D Cancer Services tracks the liver's movement through breathing at every session, enabling precise high-dose radiation to hepatocellular carcinoma and liver metastases while preserving the maximum amount of functional liver tissue. Most courses are completed in 3–5 sessions. - Liver moves 10–30 mm with breathing — more than almost any other organ - Adaptive SBRT: 3–5 sessions over 1–2 weeks - Phase 1 trial (Bujold et al.): SBRT for HCC achieved 87% 1-year local control - Rusthoven et al.: 92% local control at 2 years for liver metastases with SBRT - Daily CBCT adaptation preserves healthy liver tissue needed for function - Delivered at 5D Cancer Services, St. George, Utah — serving UT, NV, AZLast reviewed: 2026-06-08 Medically reviewed by Ritchie Stevens, MD, Radiation Oncologist on June 8, 2026. Adaptive Radiotherapy # Adaptive radiotherapy for liver cancer The liver is one of the most mobile organs in the body, shifting 10–30 mm with every breath. Conventional radiation must use wide margins to account for this motion — exposing healthy liver tissue the patient needs for survival. Adaptive SBRT on the Akesis Gemini 360 re-images the liver at every session and recalculates the plan to treat the tumor where it actually is, preserving the maximum amount of functional liver. [Call (435) 900-7060](tel:+14359007060)[Liver Cancer overview](/conditions/liver-cancer) 3–5 sessions over 1–2 weeks — outpatient, no hospital stay Why adaptive RT? ## Why Liver Cancer needs more than a fixed plan Delivering radiation to the liver is uniquely demanding. These three challenges explain why adaptive capability matters more for liver cancer than almost any other site. ### Massive respiratory motion The liver shifts 10–30 mm superiorly and inferiorly with each breath cycle — the largest organ motion of any abdominal structure. A conventional plan built on a single-moment CT cannot account for this continuous movement. ### Liver function preservation Unlike most organs, the liver cannot spare much reserve. Patients with hepatocellular carcinoma often have underlying cirrhosis, making liver function preservation critical. Wide radiation margins that irradiate healthy hepatic parenchyma risk radiation-induced liver disease. ### Proximity to hollow viscera The stomach, duodenum, and colon lie immediately adjacent to the liver. These radiation-sensitive structures are easily damaged if the plan cannot tightly conform to the liver tumor's exact daily position. Clinical Evidence ## What the evidence shows SBRT for liver tumors has accumulated robust prospective evidence over the past two decades, establishing high local control rates with an acceptable toxicity profile. ### Bujold et al.: 87% 1-year local control for HCC This prospective phase 1–2 dose escalation study treated 102 patients with hepatocellular carcinoma using SBRT. At one year, local control was 87% and median overall survival was 17 months — results comparable to other local ablative therapies in patients unsuitable for resection or ablation. [doi.org/10.1200/JCO.2012.44.1659](https://doi.org/10.1200/JCO.2012.44.1659) ### Rusthoven et al.: 92% local control for liver metastases This multi-institutional phase 1–2 trial treated 47 patients with 1–3 liver metastases using 3-fraction SBRT. Two-year local control was 92%, with no grade 4–5 toxicity. SBRT is now considered a standard treatment option for oligometastatic liver disease. [doi.org/10.1200/JCO.2008.19.6329](https://doi.org/10.1200/JCO.2008.19.6329) ### Child-Pugh A patients tolerate ablative doses Multiple studies confirm that Child-Pugh A liver function is the key eligibility criterion for ablative liver SBRT. With careful dosimetric constraints on healthy liver volume, the risk of radiation-induced liver disease (RILD) can be kept below 5% in appropriately selected patients. [doi.org/10.1016/s0360-3016(02)02846-8](https://doi.org/10.1016/s0360-3016(02)02846-8) At 5D Cancer Services ## Your treatment workflow At 5D Cancer Services, liver SBRT is planned and delivered with the highest attention to respiratory motion management and liver function preservation. 01 ### Liver function evaluation and simulation Pre-treatment labs assess liver function (Child-Pugh score, bilirubin, albumin). A planning CT — often with diagnostic MRI or PET fusion — is acquired. Contrast enhancement delineates the tumor boundary from surrounding hepatic parenchyma. 02 ### Dosimetric planning with liver constraints The plan is optimized to deliver ablative dose to the tumor while keeping healthy liver volume within published tolerance limits — typically constraining the volume of liver receiving more than 15–21 Gy to protect functional reserve. 03 ### Daily CBCT adaptation (sessions 1–5) At each session, a CBCT localizes the liver tumor's current position relative to the treatment isocenter. The Gemini 360 shifts and adapts the plan to match, then delivers the beam. Sessions typically take 30–50 minutes. 04 ### Imaging follow-up at 1, 3, and 6 months CT or MRI with contrast is used to assess local response at 4–6 weeks after the final fraction, then every 3 months for the first year. AFP is monitored in HCC patients. Local control is typically confirmed by 3 months post-treatment. Comparison ## Adaptive vs. conventional radiation Factor Adaptive RT (Gemini 360) Conventional Radiation Total sessions3–5 sessions over 1–2 weeks15–28 sessions over 3–6 weeks Daily imagingCBCT at every sessionPeriodic imaging only Respiratory managementDaily plan adaptation to liver positionLarge ITV or breath-hold technique Healthy liver preservationTight margins protect functional parenchymaWider margins irradiate more healthy liver Local control (HCC)~87–90% at 1 year~70–80% with standard IMRT RILD riskMinimized with tight dosimetric constraintsHigher with larger irradiated volumes Questions & Answers ## Frequently asked questions ### Can adaptive SBRT treat hepatocellular carcinoma (HCC)? Yes. Adaptive SBRT is an effective local treatment for HCC in patients who are not candidates for surgical resection, transplant, or thermal ablation — or whose tumors are not accessible to ablation. Child-Pugh A liver function and adequate healthy liver volume are the primary eligibility criteria. ### Can liver metastases from colon, breast, or lung cancer be treated? Yes. Adaptive SBRT for liver metastases is well-supported by prospective data, with 2-year local control rates above 90% in properly selected patients. One to three liver lesions can typically be treated in a single SBRT course. ### How does breathing motion affect liver treatment? The liver shifts 10–30 mm vertically with each breath. The Gemini 360 captures the tumor's exact position before each fraction via CBCT and adapts the plan accordingly. This eliminates the large motion margins required by conventional approaches, protecting healthy hepatic parenchyma from unnecessary radiation. ### What is radiation-induced liver disease (RILD) and how is it avoided? RILD is a syndrome of liver dysfunction caused by radiation to a large volume of hepatic tissue. It is avoided by carefully constraining the volume of healthy liver that receives high doses — keeping the mean liver dose and the volume exceeding specific dose thresholds within published safe limits. The adaptive tight margins on the Gemini 360 make these constraints easier to meet. Educational information — not medical advice The content on this page is provided for general educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay seeking it because of something you have read on this site. If you think you may have a medical emergency, call your doctor or 911 immediately. ## References - 1.Bujold A, Massey CA, Kim JJ, et al. Sequential Phase I and II Trials of Stereotactic Body Radiotherapy for Locally Advanced Hepatocellular Carcinoma. J Clin Oncol. 2013;31(13):1631–1639. doi.org/10.1200/JCO.2012.44.1659 - 2.Rusthoven KE, Kavanagh BD, Cardenes H, et al. Multi-Institutional Phase I/II Trial of Stereotactic Body Radiation Therapy for Liver Metastases. J Clin Oncol. 2009;27(10):1572–1578. doi.org/10.1200/JCO.2008.19.6329 - 3.Dawson LA, Normolle D, Balter JM, et al. Analysis of radiation-induced liver disease using the Lyman NTCP model. Int J Radiat Oncol Biol Phys. 2002;53(4):810–821. doi.org/10.1016/s0360-3016(02)02846-8 Also see: Adaptive RT by cancer type [Prostate Cancer](/adaptive-radiotherapy/prostate)[Lung Cancer](/adaptive-radiotherapy/lung)[Gynecologic Cancer](/adaptive-radiotherapy/gynecologic)[Pancreatic Cancer](/adaptive-radiotherapy/pancreatic) Please do not send Protected Health Information (PHI) by email or voicemail. Standard email is not secure — call us and we will arrange a secure channel. ## Learn More About Your Care [### What Is Adaptive Radiotherapy? The complete evidence-based guide to adaptive radiotherapy — how it works, online vs offline workflows, imaging modalities, and clinical outcomes. Learn more](/adaptive-radiotherapy) [### Liver Cancer — Condition Overview Symptoms, benefits of adaptive treatment, and what to expect during your liver cancer care at 5D Cancer Services. Learn more](/conditions/liver-cancer) [### Our Technology — Akesis Gemini 360 How the Gemini 360 delivers adaptive radiotherapy with onboard CBCT imaging, AI-assisted contouring, and per-fraction replanning. Learn more](/technology) [### Clinical Data & Case Studies Peer-reviewed evidence and real-world case studies demonstrating the Gemini 360's advantages across cancer types. Learn more](/clinical-data) [### Adaptive vs. Conventional Radiation Side-by-side comparison of adaptive radiotherapy and conventional, statically-planned radiation. Learn more](/compare/adaptive-vs-conventional-radiotherapy) Take the next step ## There is no time for cancer. You deserve the most advanced care available. Schedule a consultation with our physicians and staff today to discuss your treatment options. 1308 E 900 South, Unit B, St. George, UT 84790 [Call (435) 900-7060](tel:+14359007060)[Request Consultation](https://www.5dcancerservices.com) Please do not send Protected Health Information (PHI) by email or voicemail. Standard email is not secure — call us and we will arrange a secure channel. Bringing the most advanced Adaptive Radiotherapy to Southern Utah. No time for cancer. [TikTok](https://www.tiktok.com/@5dcancerservices?lang=en)[LinkedIn](https://www.linkedin.com/in/5d-cancer-services-corporate-bb7990404/)[Facebook](https://www.facebook.com/profile.php?id=61567576677128)[YouTube](https://www.youtube.com/channel/UCO2OmZiBQ4zXfms6XsboNPQ) #### Navigation - Technology - What Is Adaptive RT? - Clinical Data - Our Team - Conditions - Insurance - FAQ - Blog - Email UsPlease do not send Protected Health Information (PHI) by email or voicemail. Standard email is not secure — call us and we will arrange a secure channel. #### Resources - Sitemap (XML) - llms.txt - llms-full.txt - Site Index (Markdown) - Blog RSS Feed #### Contact Us 1308 E 900 South, Unit B St. George, UT 84790 [www.5dcancerservices.com](https://www.5dcancerservices.com) [(435) 900-7060 Schedule a consultation](tel:+14359007060)Please do not send Protected Health Information (PHI) by email or voicemail. Standard email is not secure — call us and we will arrange a secure channel. The information on this site is for general educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. © 2026 5D Cancer Services. All rights reserved. [Privacy Policy](/privacy-policy)[HIPAA Notice](/hipaa-notice)[Terms of Service](/terms-of-service)[Accessibility](/accessibility)[Sitemap](/sitemap.xml)[Featured on 435 Locals](https://435locals.com/directory/5d-cancer-services/)[Powered by Infuse AI](https://infuseai.agency)Sign in ## Structured data (JSON-LD) ```json [ { "@context": "https://schema.org", "@type": "WebSite", "@id": "https://www.5dcancerservices.com#website", "name": "5D Cancer Services", "url": "https://www.5dcancerservices.com", "inLanguage": "en-US", "publisher": { "@id": "https://www.5dcancerservices.com#organization" } }, { "@context": "https://schema.org", "@type": [ "MedicalOrganization", "LocalBusiness" ], "@id": "https://www.5dcancerservices.com#organization", "name": "5D Cancer Services", "alternateName": "5D Cancer Services — Adaptive Radiotherapy", "url": "https://www.5dcancerservices.com", "logo": "https://www.5dcancerservices.com/opengraph.jpg", "image": "https://www.5dcancerservices.com/opengraph.jpg", "description": "The only adaptive radiotherapy center in Utah. The Akesis Gemini 360 enables image-guided, daily-adapted cancer treatment in as few as 5 sessions for patients across Utah, Nevada, and Arizona.", "telephone": "+14359007060", "email": "info@5dcancerservices.com", "priceRange": "$", "medicalSpecialty": [ "RadiationOncology" ], "address": { "@type": "PostalAddress", "streetAddress": "1308 E 900 South, Unit B", "addressLocality": "St. George", "addressRegion": "UT", "postalCode": "84790", "addressCountry": "US" }, "geo": { "@type": "GeoCoordinates", "latitude": 37.0965, "longitude": -113.5684 }, "areaServed": [ { "@type": "State", "name": "Utah" }, { "@type": "State", "name": "Nevada" }, { "@type": "State", "name": "Arizona" } ], "openingHoursSpecification": [ { "@type": "OpeningHoursSpecification", "dayOfWeek": [ "Monday", "Tuesday", "Wednesday", "Thursday", "Friday" ], "opens": "08:00", "closes": "17:00" } ], "sameAs": [ "https://www.tiktok.com/@5dcancerservices", "https://www.linkedin.com/in/5d-cancer-services-corporate-bb7990404/", "https://www.facebook.com/profile.php?id=61567576677128", "https://www.youtube.com/channel/UCO2OmZiBQ4zXfms6XsboNPQ" ] } ] ``` ```json [ { "@context": "https://schema.org", "@type": "MedicalCondition", "@id": "https://www.5dcancerservices.com/adaptive-radiotherapy/liver#condition", "name": "Liver Cancer", "relevantSpecialty": "Radiation Oncology", "possibleTreatment": { "@id": "https://www.5dcancerservices.com/adaptive-radiotherapy/liver#procedure" }, "url": "https://www.5dcancerservices.com/adaptive-radiotherapy/liver" }, { "@context": "https://schema.org", "@type": "MedicalWebPage", "@id": "https://www.5dcancerservices.com/adaptive-radiotherapy/liver#page", "name": "Adaptive Radiotherapy for Liver Cancer | 5D Cancer Services — St. George, UT", "description": "Evidence-based guide to adaptive SBRT for liver cancer and liver metastases. The Gemini 360 tracks respiratory liver motion for precise treatment in 3–5 sessions. Serving St. George, UT, Nevada, and Arizona.", "url": "https://www.5dcancerservices.com/adaptive-radiotherapy/liver", "inLanguage": "en-US", "about": { "@id": "https://www.5dcancerservices.com/adaptive-radiotherapy/liver#procedure" }, "audience": { "@type": "MedicalAudience", "audienceType": "Patient" }, "lastReviewed": "2026-06-08", "publisher": { "@type": "MedicalOrganization", "name": "5D Cancer Services", "url": "https://www.5dcancerservices.com" } }, { "@context": "https://schema.org", "@type": "MedicalProcedure", "@id": "https://www.5dcancerservices.com/adaptive-radiotherapy/liver#procedure", "name": "Adaptive Radiotherapy for Liver Cancer", "alternateName": [ "Adaptive SBRT", "Online Adaptive Radiotherapy", "ART" ], "procedureType": "Therapeutic", "bodyLocation": "Liver", "status": "https://schema.org/EBMedicineHigh", "relevantSpecialty": "Radiation Oncology", "url": "https://www.5dcancerservices.com/adaptive-radiotherapy/liver", "performer": { "@type": "MedicalOrganization", "name": "5D Cancer Services", "url": "https://www.5dcancerservices.com" } }, { "@context": "https://schema.org", "@type": "FAQPage", "speakable": { "@type": "SpeakableSpecification", "cssSelector": [ "main h1", "main h2", "main p" ] }, "mainEntity": [ { "@type": "Question", "name": "Can adaptive SBRT treat hepatocellular carcinoma (HCC)?", "acceptedAnswer": { "@type": "Answer", "text": "Yes. Adaptive SBRT is an effective local treatment for HCC in patients who are not candidates for surgical resection, transplant, or thermal ablation — or whose tumors are not accessible to ablation. Child-Pugh A liver function and adequate healthy liver volume are the primary eligibility criteria." } }, { "@type": "Question", "name": "Can liver metastases from colon, breast, or lung cancer be treated?", "acceptedAnswer": { "@type": "Answer", "text": "Yes. Adaptive SBRT for liver metastases is well-supported by prospective data, with 2-year local control rates above 90% in properly selected patients. One to three liver lesions can typically be treated in a single SBRT course." } }, { "@type": "Question", "name": "How does breathing motion affect liver treatment?", "acceptedAnswer": { "@type": "Answer", "text": "The liver shifts 10–30 mm vertically with each breath. The Gemini 360 captures the tumor's exact position before each fraction via CBCT and adapts the plan accordingly. This eliminates the large motion margins required by conventional approaches, protecting healthy hepatic parenchyma from unnecessary radiation." } }, { "@type": "Question", "name": "What is radiation-induced liver disease (RILD) and how is it avoided?", "acceptedAnswer": { "@type": "Answer", "text": "RILD is a syndrome of liver dysfunction caused by radiation to a large volume of hepatic tissue. It is avoided by carefully constraining the volume of healthy liver that receives high doses — keeping the mean liver dose and the volume exceeding specific dose thresholds within published safe limits. The adaptive tight margins on the Gemini 360 make these constraints easier to meet." } } ] }, { "@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.5dcancerservices.com/" }, { "@type": "ListItem", "position": 2, "name": "Adaptive Radiotherapy", "item": "https://www.5dcancerservices.com/adaptive-radiotherapy" }, { "@type": "ListItem", "position": 3, "name": "Liver Cancer", "item": "https://www.5dcancerservices.com/adaptive-radiotherapy/liver" } ] } ] ```